Disclosure Of First-Time Adoption [Text Block]

ERYTECH Pharma S.A. - Filing #858938

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Comprehensive income	235,000 EUR	228,000 EUR	— EUR	194,000 EUR	— EUR	187,000 EUR	53 797 EUR	— EUR	68,000 EUR	— EUR	528,000 EUR	54 257 EUR	— EUR	72 919 EUR	400,000 EUR	— EUR	73 300 EUR	19,000 EUR
Profit (loss)	—	228,000 EUR	—	228,000 EUR	—	—	53 797 EUR	—	—	—	—	53 797 EUR	—	73 300 EUR	—	—	73 300 EUR	—